Therapeutic Opportunities of GPBAR1 in Cholestatic Diseases.
Zhang F, Xiao X, Li Y, Wu H, Deng X, Jiang Y, Zhang W, Wang J, Ma X, Zhao Y.
Zhang F, et al. Among authors: wu h.
Front Pharmacol. 2022 Jan 13;12:805269. doi: 10.3389/fphar.2021.805269. eCollection 2021.
Front Pharmacol. 2022.
PMID: 35095513
Free PMC article.
Review.